Translational Oncology
- Biomarker discovery
- Mouse clinical trial
- 61 PDX-derived primary cancer cell lines
- Drug-resistant xenograft models
- Combination therapy platform including radiation
- World leading genome sequencing and bioinformatics capability

translational Oncology 20200513
Related Content
WuXi Biology offers an integrated package of preclinical cancer pharmacology services for targeted oncology and immuno-oncology. Our platform includes in...
VIEW RESOURCEHigh-dimensional (HD) flow cytometry allows researchers to perform deep phenotyping of immune cells at the single cell level with increased...
VIEW RESOURCE